CreditReports.dk
HomeScreen companies

NORDIC BIOSCIENCE A/S Financials, key figures and credit report

CVR number: 30799968 Advertising protected Established 2007 Industry: 72 Scientific research and development
Company contact details

The company is advertising protected in the CVR register and does not want to be contacted for direct marketing.

Herlev Hovedgade 205, 2730 Herlev info@nordicbio.com tel: 44525252 www.nordicbioscience.com
Net sales 379.3 mDKK FY 2025 +16.8% vs 2024
EBIT margin 33.3 % FY 2025 +3.5 pp vs 2024
Net debt 116.3 mDKK FY 2025 +339% vs 2024
Quick ratio 1.1 FY 2025 -0 vs 2024

Income statement (mDKK)

2021
2022
2023
2024
2025
Fiscal period length1212121212
Net sales246.89313.57221.67324.92379.35
Other operating income3.032.3610.828.446.49
Costs of manufacturing-31.87-50.32-57.04-61.52-87.24
Gross profit215.02263.25164.63263.40292.11
Costs of management-31.46-40.96-47.66-51.81-58.76
Other operating expenses-77.00-84.86- 100.63- 122.92- 113.36
EBIT109.58139.7927.1597.11126.48
Other financial income0.000.4411.175.802.36
Other financial expenses-0.88-1.78-1.26-1.31-2.93
Net income from associates (fin.)-0.34-0.34
Pre-tax profit108.35138.1137.07101.60125.91
Income taxes-18.48-24.87-8.21-23.21-29.38
Net earnings89.87113.2328.8678.3996.54

Assets (mDKK)

2021
2022
2023
2024
2025
Development expenditure4.998.427.974.060.93
Intangible assets total4.998.427.974.060.93
Land and waters68.2966.9365.6464.4384.26
Machinery and equipment9.439.1613.1810.728.47
Tangible assets total77.7276.0978.8175.1592.73
Investments total
Long term receivables total
Raw materials and consumables7.6227.40
Finished products/goods23.6119.9425.99
Inventories total7.6227.4023.6119.9425.99
Current trade debtors20.4735.7217.8782.9122.83
Current amounts owed by group member comp.36.3465.7788.81137.36253.25
Prepayments and accrued income0.220.492.431.443.22
Current other receivables10.170.3816.6315.9963.74
Current deferred tax assets16.31
Short term receivables total83.50102.36125.74237.70343.04
Cash and bank deposits59.4657.6066.1088.5220.67
Cash and cash equivalents59.4657.6066.1088.5220.67
Balance sheet total (assets)233.28271.87302.24425.37483.36

Equity and liabilities (mDKK)

2021
2022
2023
2024
2025
Share capital10.0010.0010.0010.0010.00
Shares repurchased100.0050.0040.0080.00120.00
Retained earnings- 142.86- 101.57-21.30-57.14-95.33
Profit of the financial year89.87113.2328.8678.3996.54
Shareholders equity total57.0171.6757.56111.25131.21
Provisions2.953.261.220.11
Non-current loans from credit institutions45.3542.2039.8337.0433.54
Non-current leasing loans3.072.401.97
Non-current liabilities total45.3542.2042.9039.4435.51
Current loans from credit institutions3.273.262.822.813.46
Advances received72.0772.84
Current trade creditors6.9112.237.4817.066.12
Current owed to group member41.14100.01
Short-term deferred tax liabilities22.675.627.5823.8829.13
Other non-interest bearing current liabilities20.2915.2113.9422.3324.87
Accruals and deferred income5.724.75166.70207.38152.95
Current liabilities total130.92155.05198.52273.45316.54
Balance sheet total (liabilities)233.28271.87302.24425.37483.36
Page generated